Pinana JL, Heras I, Aiello TF, Garcia-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, Garcia-Vidal C, Arroyo I, Soler-Espejo E, Lopez-Corral L, Avendano-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernandez-Medina L, Gonzalez-Santillana C, Morell J, Hernandez-Rivas JA, Rodriguez-Galvez P, Mico-Cerda M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PubMed PMID: 37896843; PubMed Central PMCID: PMC10612015.
AÑO: 2023; IF: 3.8